Ozempic Alternatives: Your Options When Ozempic Is Unavailable or Too Expensive

Ozempic — the brand-name semaglutide injection made by Novo Nordisk — has become one of the most talked-about medications of the past decade. Originally approved for type 2 diabetes in 2017, it quickly became a first-choice treatment for weight loss due to its remarkable clinical efficacy. The problem? Millions of people want it, and between insurance denials, ongoing supply shortages, and a list price hovering around $935 per month, access is far from guaranteed.

If you've been told your pharmacy is out of stock, if your insurance won't cover it, or if the price is simply out of reach, you have real, clinically effective options. Here's everything you need to know about the best alternatives to Ozempic — what they are, how they compare, and which one might be right for you.

Why People Look for Ozempic Alternatives

There are three primary reasons patients come to us searching for an Ozempic substitute:

• Cost: At $935/month without insurance, Ozempic is out of reach for many patients. Over a year, that's more than $11,000 — simply not sustainable for most households.
• Supply shortages: The FDA placed semaglutide on its official drug shortage list beginning in 2022. While supply has improved, regional shortages still occur, and some patients face weeks or months without access to their medication.
• Insurance denials: Even patients with insurance often find their GLP-1 coverage denied, particularly if they don't have a diabetes diagnosis. Many plans still do not cover obesity medications, viewing them as "lifestyle" treatments despite overwhelming clinical evidence of medical necessity.

Whatever your reason for looking, the good news is that the landscape of GLP-1 alternatives has expanded significantly. Let's go through them one by one.

Compounded Semaglutide: The #1 Ozempic Alternative

When we talk to patients who need an Ozempic alternative, compounded semaglutide is almost always where we start — and for good reason. It contains the exact same active ingredient as Ozempic: semaglutide. The molecule is identical. The pharmacological mechanism is identical. The clinical weight-loss pathway is identical.

What's different is the supply chain. Compounded semaglutide is produced by FDA-registered 503B outsourcing facilities — specialized pharmaceutical compounding labs that operate under current Good Manufacturing Practice (cGMP) standards. These facilities are inspected by the FDA and are required to produce medications to strict quality and sterility standards. The finished product isn't FDA-approved as a branded drug, but the active ingredient and its mechanism are well-established and identical to the brand-name version.

The price difference is dramatic. Where Ozempic costs around $935/month, compounded semaglutide through a telehealth provider like Truventa Medical typically runs $199–$349 per month — an 65–78% reduction. For patients who plan to use this medication long-term (which most weight-loss patients do), that savings compounds into tens of thousands of dollars over time.

Compounded semaglutide requires a prescription from a licensed physician, just like the brand-name version. Through telehealth, you can receive physician supervision, dose optimization, and ongoing monitoring — all without leaving your home.

Wegovy: The Higher-Dose Semaglutide Option

Wegovy is Novo Nordisk's other semaglutide product — this one FDA-approved specifically for chronic weight management in adults with a BMI of 30+ (or 27+ with a weight-related condition). It uses the same active ingredient as Ozempic but goes up to a higher maximum dose of 2.4mg per week versus Ozempic's 2mg ceiling.

Clinical trial data from the STEP program shows that the 2.4mg dose produces an average weight loss of approximately 14.9% of body weight over 68 weeks — slightly higher than the 12–15% typically seen with Ozempic's lower doses. For patients who have plateaued on 1–2mg, Wegovy's higher ceiling can provide additional benefit.

The downside? Wegovy costs approximately $1,349/month — even more expensive than Ozempic — and insurance coverage for it is limited because it's classified as an obesity medication rather than a diabetes drug. It's also been subject to its own supply shortages. If you have insurance that covers obesity medications or a coupon that makes it affordable, Wegovy is an excellent option. For most patients, however, the cost barrier is prohibitive.

Tirzepatide (Zepbound/Compounded): The Step-Up Alternative

If semaglutide is the gold standard, tirzepatide is the upgrade. FDA-approved as Zepbound for weight loss (and Mounjaro for diabetes), tirzepatide targets two incretin receptors — GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual-agonist mechanism produces even greater appetite suppression and weight loss than semaglutide alone.

The SURMOUNT-1 trial, which studied tirzepatide specifically for weight management, showed average body weight loss of 20.9% at the highest dose (15mg) over 72 weeks. That's nearly 50% more weight loss than the already-impressive semaglutide results. Approximately 36% of participants lost more than 25% of their body weight — results that were previously only achievable with bariatric surgery.

Like semaglutide, tirzepatide is also available as a compounded option at a significantly lower cost than brand-name Zepbound (which lists at approximately $1,060/month). Compounded tirzepatide runs $249–$399/month through telehealth providers and is available by physician prescription after consultation.

The side effect profile of tirzepatide is similar to semaglutide — primarily GI symptoms like nausea, constipation, and occasional vomiting — though some patients find one tolerates better than the other. If you're looking for the most effective Ozempic alternative, tirzepatide is the strong clinical choice.

Oral GLP-1: Rybelsus (Oral Semaglutide)

For patients who prefer to avoid injections entirely, Rybelsus offers an oral semaglutide option. It's the same molecule as Ozempic, formulated as a daily tablet. Rybelsus is FDA-approved for type 2 diabetes, and physicians may prescribe it off-label for weight loss.

The challenge with Rybelsus is bioavailability — oral semaglutide is significantly less absorbed than the injectable form due to the way GLP-1 drugs are degraded in the digestive system. The maximum dose of Rybelsus (14mg daily) produces roughly half the weight loss of injectable semaglutide at equivalent doses. It's a reasonable option for patients with needle phobia or who are managing diabetes with a weight-loss goal, but it's not the most powerful choice for significant weight loss.

Full Comparison: All Ozempic Alternatives

Here's a side-by-side look at every major alternative to Ozempic for weight loss, including approximate monthly costs, average weight loss results, and availability.

How Telehealth Makes Access to GLP-1 Alternatives Easier

Before the rise of telehealth for weight loss, getting a GLP-1 prescription typically required an in-person visit with an endocrinologist or obesity medicine specialist — often with a wait time of weeks or months. Telehealth has completely changed this dynamic.

Through providers like Truventa Medical, the process looks like this:

1. Complete a free online health intake — about 10 minutes, covering your health history, current medications, and weight loss goals.
2. Physician review — a licensed physician reviews your intake within 24 hours and determines if you're a candidate for GLP-1 therapy.
3. Prescription issued — if appropriate, your physician writes a prescription for compounded semaglutide or tirzepatide.
4. Medication shipped to your door — your medication arrives from an FDA-registered compounding pharmacy, typically within 3–5 business days.
5. Ongoing check-ins — your care team monitors your progress, adjusts dosing, and provides support throughout your journey.

You don't need insurance. You don't need a prior diagnosis. You don't need to live near a specialist. If you're an adult with a BMI of 27 or above and no contraindications, you may qualify for treatment today.

For patients who have been turned away from brand-name Ozempic due to cost or availability, telehealth-prescribed compounded semaglutide is the most direct path to the same clinical outcome. The molecule is what does the work — and that molecule is accessible right now.